Jason Rowland
Psychiatry · Indianapolis, INNPI 1114979051
Payments from drug & device makers
Across 227 payments — averaging $17.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Supernus Pharmaceuticals, Inc.$793
- AbbVie$601
- Vanda Pharmaceuticals Inc.$373
- Teva Pharmaceuticals USA, Inc.$282
- Axsome Therapeutics, Inc.$280
- Corium, LLC$217
- plus $2K from 19 others
What the payments were for
- Food & beverage$4,05099%
- Education$211%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 50 | $793 |
| AbbVie(2 entities) | 41 | $601 |
| Vanda Pharmaceuticals Inc. | 16 | $373 |
| Teva Pharmaceuticals USA, Inc. | 14 | $282 |
| Axsome Therapeutics, Inc. | 13 | $280 |
| Corium, LLC | 11 | $217 |
| Lundbeck LLC | 13 | $203 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $180 |
| Johnson & Johnson | 9 | $177 |
| Otsuka America Pharmaceutical, Inc. | 9 | $157 |
| Noven Therapeutics, LLC | 7 | $146 |
| Ironshore Pharmaceuticals Inc. | 6 | $95 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $88 |
| Neos Therapeutics, LP | 4 | $86 |
| Tris Pharma Inc | 4 | $68 |
| Alkermes, Inc. | 3 | $55 |
| Shire North American Group Inc | 2 | $46 |
| Vertical Pharmaceuticals, LLC | 3 | $43 |
| Neurocrine Biosciences, Inc. | 2 | $42 |
| OWP Pharmaceuticals, Inc. | 2 | $39 |
| Neuronetics, Inc. | 1 | $25 |
| Jazz Pharmaceuticals Inc. | 1 | $23 |
| Rhodes Pharmaceuticals L.p. | 1 | $18 |
| Collegium Pharmaceutical, Inc. | 1 | $17 |
| Adlon Therapeutics L.p. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,070 in reported general payments places this provider in the 80th percentile of 514 psychiatry providers in Indiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Vilazodone Hcl | 33 | $5,922 |
| Guanfacine Hcl ErGuanfacine Hcl | 15 | $5,780 |
| Bupropion XlBupropion Hcl | 19 | $987 |
| Buspirone Hcl | 13 | $366 |
| Lamotrigine | 14 | $207 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Indianapolis
- Anantha ShekharIndianapolis$433K
- Leslie HulvershornIndianapolis$159K
- Charles BeasleyIndianapolis$129K
- Alan BreierIndianapolis$114K
- John NurnbergerIndianapolis$104K
- Susan ConroyIndianapolis$73K
- Dmitry ArbuckIndianapolis$40K
- Michael FrancisIndianapolis$26K
- Albert AllenIndianapolis$24K
- Jerad DaltonIndianapolis$20K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.